ACE Report Cover
Efficacy of corticosteroid injection, with and without distension, for adhesive capsulitis
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
اللغة
Download Download Download
تحميل
Cite this Report Cite this Report Cite this Report
اقتباس
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ المفضلة
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
اللغة
Download Download Download
تحميل
Cite this Report Cite this Report Cite this Report
اقتباس
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ المفضلة
SHOULDER & ELBOW
Efficacy of corticosteroid injection, with and without distension, for adhesive capsulitis .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2016;4(16):17 BMC Musculoskelet Disord. 2016 May 26;17(1):232.
المؤلفون المساهمون

SP Sharma A Bærheim R Moe-Nilssen A Kvåle

106 patients with adhesive capsulitis were randomized to one of three groups to determine which mode of conservative therapy - corticosteroid injections with distension, corticosteroid injections only, or treatment-as-usual (verbal education, use of other conservative therapy) - was associated with the greatest improvement in shoulder pain, function, and range of motion on the short-term (4 and 8 weeks) and long-term (12 months). Results demonstrated that patients in both corticosteroid injection intervention groups had significant improvements in pain, function, abduction, internal rotation, and external rotation when compared to the usual treatment group when assessed at 4 and 8 weeks. Long-term improvements in any outcome measure (12 months) between all groups and efficacy between the two intervention groups were comparable when evaluated.


تفاصيل تمويل المنشور +
التمويل:
Non-Industry funded
الراعي:
General Practice Research Fund of The Norwegian Medical Association, Dr. Trygve Gythfeldt Research Fund
Conflicts:
None disclosed

مخاطر التحيز

6/10

معايير الإبلاغ

17/20

مؤشر الهشاشة

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

نعم = 1

غير مؤكد = 0.5

غير ذي صلة = 0

لا = 0

يقيّم تقييم معايير الإبلاغ الشفافية التي يبلغ بها المؤلفون عن الخصائص المنهجية والتجريبية للتجربة في المنشور. ينقسم التقييم إلى خمس فئات معروضة أدناه.

4/4

Randomization

3/4

Outcome Measurements

2/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

مؤشر الهشاشة هو أداة تساعد في تفسير النتائج المهمة، وتوفر مقياسًا لقوة النتيجة. ويمثل مؤشر الهشاشة عدد الأحداث المتتالية التي يجب إضافتها إلى نتيجة ثنائية التفرع لجعل النتيجة غير مهمة. يمثل الرقم الصغير نتيجة أضعف ويمثل الرقم الكبير نتيجة أقوى.

لماذا كانت هناك حاجة لهذه الدراسة الآن؟

Adhesive capsulitis, also known as "frozen shoulder", is diagnosed as a long-lasting condition characterized by recurrent onset of pain, progressive stiffness, and reduced shoulder range of motion. These symptoms are further associated with interference in activities of daily living and increased dependency by the elderly. Several modes of conservative therapy have been developed to address and mitigate these symptoms (ie. nonsteroidal anti-inflammatory drugs, intraarticular glucocorticosteroid injections, physical therapy, and manipulation under anaesthetic and hydrodilation), however recent study has been largely unsuccessful in finding an optimal treatment modality. Therefore, the aim of this study was to determine the short- and long-term effects of multiple corticosteroid injections with distension, when compared to injection alone or treatment-as-usual.

ما هو سؤال البحث الرئيسي؟

For patients with adhesive capsulitis, how does conservative treatment with either corticosteroid injections and distension, corticosteroid injections alone, or standard treatment compare in improved pain, disability, and passive range of motion when assessed throughout a 12-month follow-up period?

خصائص الدراسة +
Population:
106 patients, older than 18 years of age, with clinical evidence of adhesive capsulitis. Patients were required to demonstrate reduced passive range of motion (PROM) by a least 30% in two or more of three shoulder movements (abduction, external rotation, and internal rotation).
Intervention:
Steroid Injection and Lidocaine (IS) group: patients were allocated to treatment with 4 triamcinolone 20 mg injections with Lidocaine 10 mg/mL 3mL only (n=36, 34 completed follow-up; mean age= 52+/-8.3, 21F). Median duration of symptoms was 7.5 months (2.5-18.0). Steroid Injection, Lidocaine, and Saline Distention (ISD) group: patients were allocated to treatment with 4 triamcinolone 20 mg injections with Lidocaine 10 mg/mL 3mL and physiological sodium chloride 9 mg/mL (total injection volume was 8 mL to 20 mL, where limiting factors on injected volume included difficulty in further injection of increase in pain during injection) (n=34, 32 completed follow-up; mean age= 53+/-9.2, 21F). Median duration of symptoms was 7.0 months (3.0-37.0).
Comparison:
Treatment-as usual (TAU) group: patients were referred to other modes of conventional treatment, such as physiotherapy or oral medication, or oral corticosteroid medication. Patients were allowed to receive conservative therapy (including corticosteroid injections) after completion of the 8-week intervention period (n=36, 21 completed follow-up; mean age= 54+/-6.9, 19F). Median duration of symptoms was 6.0 months (3.0-24.0)
Outcomes:
Primary outcome of interest was the shoulder pain and disability index (SPADI, 0 to 100). Pain measured on a 10-point numerical pain rating scale (NPRS, 0 to 10) and passive range of motion (PROM) measured through abduction, internal rotation and external rotation were secondary outcomes of interest.
Methods:
RCT: prospective, assessor-blinded
Time:
Outcomes of interest were evaluated on the first visit and after 4 weeks, 8 weeks, and 12 months.
ما هي النتائج المهمة؟
  • Both intervention groups were observed with significant improvement in SPADI when compared to the TAU group at 4 and 8 weeks (IS vs. TAU MD=-20.8 [28.9 to -12.7], p<0.001 | ISD vs. TAU MD= -21.7 [-29.4 to -14.0], p<0.001); significant was not maintained at 12 months. Additionally, differences in SPADI scores between IS and ISD groups were not significant.
  • Both intervention groups were observed with significant improvement in NPRS scores when compared to the TAU group at 4 and 8 weeks (IS vs. TAU MD=-2.0 [-2.8 to -1.1], p<0.001 | ISD vs. TAU MD= -2.2 [-3.0 to -1.4], p<0.001); differences in NPRS scores between IS and ISD groups were not significant.
  • Patients in the IS group (MD=8.3 [2.3 to 14.3]) and the ISD group (MD=12.8 [6.6 to 18.9]) were observed with significantly greater improvement in abduction when compared to the TAU group at 4 and 8 weeks (p=0.01 and p=0.001 respectively).
  • Patients in the IS group (MD=10.8 [5.8 to 15.9]) and the ISD group (MD=11.9 [6.8 to 17]) were observed with significantly greater improvement in internal rotation when compared to the TAU group at 4 and 8 weeks (p=0.001 for both).
  • Patients in the IS group (MD=5.0 [2.8 to 7.2]) and the ISD group (MD=5.1 [2.9 to 7.2]) were observed with significantly greater improvement in external rotation when compared to the TAU group at 4 and 8 weeks (p=0.001 for both).
  • Differences in all measurements of passive range of motion (abduction, internal rotation, and external rotation) were not significant between all three groups, or when intervention groups were compared to the TAU group, at 12 months.
  • 17% and 12% of patients in the IS and ISD group respectively experiences minor transitory side effects (including flushing and after-pain); no other minor or adverse effects were observed.
ما الذي يجب أن أتذكره أكثر؟

For patients undergoing conservative treatment for adhesive capsulitis, use of corticosteroid injection with or without distension was associated with significantly improved pain, function, and range of motion when compared to the treatment-as-usual (TAU group) at 4 and 8 weeks. However, when assessed at 12 months, outcomes scores were comparable between study groups. Additionally, differences between pain, function and range of motion outcomes never reached statistical significance when the two corticosteroid injection intervention groups were compared throughout the study.

كيف سيؤثر ذلك على رعاية مرضاي؟

The results of this study suggest that corticosteroid injection treatment, with or without distention, may provide patients with significant short-term reduction of adhesive capsulitis symptoms when compared to usual treatment. Nevertheless, outcome after 1 year does not appear to differ between treatment option. Further randomized controlled trials are needed to verify consistent short-term benefit of corticosteroid injection, with or without distension, in cases of adhesive capsulitis. Additionally, methods offered in the treatment-as-usual group were heterogenous, with the possibility remaining that there may be differences depending on specific control interventions.

تنويه

هذا المحتوى الموجود في هذه الصفحة هو لأغراض إعلامية فقط وليس الغرض منه أن يكون بديلاً عن المشورة الطبية المتخصصة أو التشخيص أو العلاج. إذا كنت بحاجة إلى علاج طبي، اطلب دائمًا مشورة طبيبك أو اذهب إلى أقرب قسم طوارئ إليك. الآراء والمعتقدات ووجهات النظر التي يعبر عنها الأفراد في المحتوى الموجود في هذه الصفحة لا تعكس آراء ومعتقدات ووجهات نظر أورثوإيفيدنس.

0 من 4 مقالات مجانية شهرية غير مقفلة
لقد وصلت إلى الحد الأقصى لمشاهدة 4 من 4 مقالات مجانية هذا الشهر

ادخل إلى OrthoEvidence مقابل 1.99 دولارًا أمريكيًا في الأسبوع.

ابق على اتصال بأحدث الأدلة. قم بالإلغاء في أي وقت.
  • تقييمات نقدية لأحدث التجارب المعشاة ذات الشواهد عالية التأثير والمراجعات المنهجية في مجال جراحة العظام
  • الوصول إلى محتوى المدونة الصوتية OrthoEvidence، بما في ذلك التعاون مع مجلة جراحة العظام والمفاصل، والمقابلات مع الجراحين المعترف بهم دولياً، ومناقشات المائدة المستديرة حول أخبار وموضوعات جراحة العظام
  • الاشتراك في نشرة The Pulse، وهي نشرة إخبارية مبنية على الأدلة مرتين أسبوعيًا مصممة لمساعدتك على اتخاذ قرارات سريرية أفضل
Upgrade
أهلاً بعودتك!
هل نسيت كلمة المرور؟
ابدأ تجربتك المجانية اليوم!

سيكون حسابك تابعًا لـ
ويتضمن وصولًا مجانيًا إلى OrthoEvidence


أو
هل نسيت كلمة المرور؟

أو
يرجى التحقق من بريدك الإلكتروني

في حالة وجود حساب بعنوان البريد الإلكتروني المقدم، سيتم إرسال بريد إلكتروني لإعادة تعيين كلمة المرور إليك. إذا كنت لا ترى بريدًا إلكترونيًا، يرجى التحقق من مجلد الرسائل غير المرغوب فيها أو البريد غير المرغوب فيه.

لمزيد من المساعدة اتصل بفريق الدعم لدينا.

يرجى تسجيل الدخول لتفعيل هذه الميزة

للوصول إلى هذه الميزة، يجب تسجيل الدخول إلى حساب OrthoEvidence نشط. يرجى تسجيل الدخول أو إنشاء حساب تجريبي مجاني.

ترجمة تقرير ACE

تستخدم OrthoEvidence خدمة ترجمة من طرف ثالث لإتاحة المحتوى بلغات متعددة. يُرجى ملاحظة أنه على الرغم من بذل كل جهد ممكن لضمان الدقة، إلا أن الترجمات قد لا تكون دائمًا مثالية.

كيفية الاستشهاد بهذا ACE Report

OrthoEvidence. Efficacy of corticosteroid injection, with and without distension, for adhesive capsulitis. OE Journal. 2016;4(16):17. Available from: https://myorthoevidence.com/AceReport/Show/

نسخ الاقتباس
يرجى تسجيل الدخول لتفعيل هذه الميزة

للوصول إلى هذه الميزة، يجب تسجيل الدخول إلى حساب OrthoEvidence نشط. يرجى تسجيل الدخول أو إنشاء حساب تجريبي مجاني.

ميزة العضو المميز

للوصول إلى هذه الميزة، يجب عليك تسجيل الدخول إلى حساب OrthoEvidence المميز.

شارك هذا ACE Report